The establishment of a Strategic Bitcoin Reserve (SBR) in the U.S. is a "monumental endorsement" of the world's largest ...

Equities researchers at HC Wainwright increased their FY2026 earnings estimates for shares of Oncolytics Biotech in a ...

Investment analysts at HC Wainwright dropped their Q1 2025 earnings per share estimates for Cidara Therapeutics in a report ...

Fintel reports that on March 13, 2025, HC Wainwright & Co. initiated coverage of Perspective Therapeutics (NYSEAM:CATX) with ...

Shares of Core Scientific Inc. (CORZ) gained almost 8% in Tuesday’s regular session and extended gains during after-hours ...

H.C. Wainwright lowered the firm’s price target on Vigil Neuroscience (VIGL) to $14 from $17 and keeps a Buy rating on the shares ahead of ...

H.C. Wainwright lowered the firm’s price target on Cartesian Therapeutics (RNAC) to $40 from $45 and keeps a Buy rating on the shares. The firm ...

Nanoscope Therapeutics Inc., a biotech company committed to restoring vision in individuals who are blind or losing vision ...

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from ...

H.C. Wainwright & Co. initiates a Buy rating on Perspective Therapeutics, citing promising cancer radiotherapy assets.

Quantum computing continues to advance rapidly, which has been helping businesses get new opportunities related to security, ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...